Skip to main content

Tourmaline Bio, Inc.

TRMLDelisted Oct 28, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827506

Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Tourmaline Bio, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
92
+9 vs. Q2 2024
Shares held
21.0M
+1.60M (+8.2%) vs. Q2 2024
Total value
$540.7M
+$290.9M (+116.4%) vs. Q2 2024
New holders
22
25 more added
Sold out
13
27 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRML on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 92 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 48 institutionsQ4 2021: 51 institutionsQ1 2022: 51 institutionsQ2 2022: 59 institutionsQ3 2022: 56 institutionsQ4 2022: 54 institutionsQ1 2023: 54 institutionsQ2 2023: 58 institutionsQ3 2023: 49 institutionsQ4 2023: 54 institutionsQ1 2024: 96 institutionsQ2 2024: 84 institutionsQ3 2024: 92 institutionsQ4 2024: 101 institutionsQ1 2025: 107 institutionsQ2 2025: 109 institutionsQ3 2025: 134 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $540.7M
Q1 2021: $0Q2 2021: $379.4MQ3 2021: $349.4MQ4 2021: $456.7MQ1 2022: $286.9MQ2 2022: $130.4MQ3 2022: $72.1MQ4 2022: $27.4MQ1 2023: $50.6MQ2 2023: $79.7MQ3 2023: $77.1MQ4 2023: $338.2MQ1 2024: $469.9MQ2 2024: $272.0MQ3 2024: $540.7MQ4 2024: $463.6MQ1 2025: $364.3MQ2 2025: $384.8MQ3 2025: $1.03BQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TRML and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 2025134$1.03B
Q2 2025109$384.8M
Q1 2025107$364.3M
Q4 2024101$463.6M
Q3 202492$540.7M
Q2 202484$272.0M
Q1 202496$469.9M
Q4 202354$338.2M
Q3 202349$77.1M
Q2 202358$79.7M
Q1 202354$50.6M
Q4 202254$27.4M
Q3 202256$72.1M
Q2 202259$130.4M
Q1 202251$286.9M
Q4 202151$456.7M
Q3 202148$349.4M
Q2 202150$379.4M
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Tourmaline Bio, Inc.; share changes are against Q2 2024.

Institutions holding TRML in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Swiss National Bank0$00.00%−25,200−100.0%Sold out
Alpine Global Management, LLC0$00.00%−22,648−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−11,686−100.0%Sold out
Janus Henderson Group PLC0$00.00%−11,500−100.0%Sold out
Simplex Trading, LLC0$00.00%−104−100.0%Sold out
BlackRock Inc.––––Not filed